Hideki Hanaoka

5.0k citations

78 papers · 2.8k indexed · 2 hit papers · h-index 22

Immunology top 5%
- Immunotherapy and Immune Responses 8
- Immune Cell Function and Interaction 7
Plant Science top 2%
Oncology top 5%
- CAR-T cell therapy research 5
- Cancer Immunotherapy and Biomarkers 4
Epidemiology top 5%
- Cervical Cancer and HPV Research 4
Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments 7
Economics and Econometrics
- Health Systems, Economic Evaluations, Quality of Life 4
Experimental and Cognitive Psychology
- Mental Health Research Topics 4

Co-authors: Tomohiko Kato Yoshinori Ohsumi Takeshi Noda Satoshi Tabata Shusei Sato Kohki Yoshimoto Yumiko Shirano Daisuke Shibata
Cited by: Immunology Plant Science Oncology
Journals: Journal of Clinical Oncology (3 papers)SHILAP Revista de lepidopterología (1 paper)The Journal of Immunology (1 paper)
Partner nations: Japan United States United Kingdom

In The Last Decade

Hideki Hanaoka

72 papers receiving 2.7k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Hideki Hanaoka

Since Specialization

Citations

This map shows the geographic impact of Hideki Hanaoka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Hanaoka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Hanaoka more than expected).

Fields of papers citing papers by Hideki Hanaoka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideki Hanaoka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Hanaoka. The network helps show where Hideki Hanaoka may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hideki Hanaoka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hideki Hanaoka Line = papers co-authored together Hideki Hanaoka links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Evaluation of the efficacy of angiotensin receptor–neprilysin inhibitor in patients with aortic stenosis undergoing transcatheter aortic valve implantation: protocol for a randomised, open-label, controlled study BMJ Open ·Hideki Kitahara,Shinji OKITA,Takeaki Sugawara,Hiroaki Yaginuma,Hiroki Goto,Hiroaki Yamamoto,Tomoyoshi Kanda,Kaoru Matsuura,Yosuke Inaba,Hideki Hanaoka,Goro Matsumiya,Yoshio Kobayashi	2025	0
2	Efficacy and safety of a novel pain management device, AT-04, for endometriosis-related pain: study protocol for a phase III randomized controlled trial Reproductive Health ·Hiroshi Ishikawa,Osamu Yoshino,Fuminori Taniguchi,Tasuku Harada,Mikio Momoeda,Yutaka Osuga,Tamiki Hikake,Youko Hattori,Michiko Hanawa,Yosuke Inaba,Hideki Hanaoka,Kaori Koga	2024	1
3	Digital cognitive–behavioural therapy application compared with zolpidem for the treatment of insomnia: protocol for an exploratory randomised controlled trial BMJ Open ·Eiji Shimizu,Daisuke Sato,Yoshiyuki Hirano,Haruna Ebisu,Yuki Kagayama,Hideki Hanaoka	2024	0
4	Reduced-dose versus high-dose glucocorticoids added to rituximab on remission induction in ANCA-associated vasculitis: predefined 2-year follow-up study Annals of the Rheumatic Diseases ·Shunsuke Furuta,Daiki Nakagomi,Y Kobayashi,Masaki Hiraguri,Takao Sugiyama,Koichi Amano,Takeshi Umibe,Hajime Kono,Kazuhiro Kurasawa,Yasuhiko Kita,Ryutaro Matsumura,Yuko Kaneko,Keita Ninagawa,Keiju Hiromura,Shin‐ichiro Kagami,Yosuke Inaba,Hideki Hanaoka,Kei Ikeda,Hiroshi Nakajima	2023	12
5	Exploratory clinical trial to evaluate the efficacy and safety of transdermal electrical stimulation in patients with central retinal artery occlusion PLoS ONE ·Gen Miura,T. Fujiwara,T. Iwase,Yoshihito Ozawa,Yuki Shiko,Yohei Kawasaki,Tomohiro Nizawa,Tomoaki Tatsumi,Takayuki Baba,Takuji Kurimoto,Sotaro Mori,Makoto Nakamura,Hideki Hanaoka,Shuichi Yamamoto	2023	4
6	Phase Ib study of durvalumab (MEDI4736) in combination with carbon-ion radiotherapy and weekly cisplatin for patients with locally advanced cervical cancer (DECISION study): study protocol for a prospective open-label single-arm study BMJ Open ·Noriyuki Okonogi,Hirokazu Usui,Kazutoshi Murata,Makoto Hori,Tomoya Kurokawa,T. Fujiwara,Yasuhisa Fujii,Michiko Hanawa,Yohei Kawasaki,Yoko Hattori,Kazuko Suzuki,Kyoko Tsuyuki,Masaru Wakatsuki,Sumitaka Hasegawa,Shigeru Yamada,Hideki Hanaoka,Makio Shozu,Hiroshi Tsuji	2022	7
7	Evaluating the efficacy and safety of transdermal electrical stimulation on the visual functions of patients with retinitis pigmentosa: a clinical trial protocol for a prospective, multicentre, randomised, double-masked and sham-controlled design (ePICO trial) BMJ Open ·Gen Miura,Yoshihito Ozawa,Yuki Shiko,Yohei Kawasaki,T. Iwase,T. Fujiwara,Takayuki Baba,Hideki Hanaoka,Shuichi Yamamoto	2022	3
8	Implementation of a self-sampling HPV test for non-responders to cervical cancer screening in Japan: secondary analysis of the ACCESS trial Scientific Reports ·Misuzu Fujita,Kengo Nagashima,Minobu Shimazu,Misae Suzuki,Ichiro Tauchi,Miwa Sakuma,Setsuko Yamamoto,Hideki Hanaoka,Makio Shozu,N Tsuruoka,T. Kasai,Akira Hata	2022	7
9	Antibody responses to BNT162b2 mRNA COVID-19 vaccine and their predictors among healthcare workers in a tertiary referral hospital in Japan Clinical Microbiology and Infection ·Takahiro Kageyama,Kei Ikeda,Shigeru Tanaka,Toshibumi Taniguchi,Hidetoshi Igari,Yoshihiro Onouchi,Atsushi Kaneda,Kazuyuki Matsushita,Hideki Hanaoka,Taka‐aki Nakada,Seiji Ohtori,Ichiro Yoshino,Hisahiro Matsubara,Toshinori Nakayama,Koutaro Yokote,Hiroshi Nakajima	2021	91
10	The Curriculum and Syllabus for Training Clinical Data Managers Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics ·Hiroshi Watanabe,Hideo Kusuoka,Takashi Moritoyo,Hideki Hanaoka	2020	0
11	Medroxyprogesterone acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and endometrial carcinoma: trial protocol for a prospective, randomised, open, blinded-endpoint design, dose-response trial (FELICIA trial) BMJ Open ·Akira Mitsuhashi,Yohei Kawasaki,Makoto Hori,T. Fujiwara,Hideki Hanaoka,Makio Shozu	2020	27
12	Clinical Trial to Evaluate Safety and Efficacy of Transdermal Electrical Stimulation on Visual Functions of Patients with Retinitis Pigmentosa Scientific Reports ·Gen Miura,Takeshi Sugawara,Yohei Kawasaki,Tomoaki Tatsumi,Tomohiro Nizawa,Takayuki Baba,Hideki Hanaoka,Shuichi Yamamoto	2019	19
13	Efficacy of intravenous nicorandil for fractional flow reserve assessment: study protocol for a crossover randomised trial BMJ Open ·Takeshi Nishi,Hideki Kitahara,Yoshihide Fujimoto,Takashi Nakayama,Kazumasa Sugimoto,Kengo Nagashima,Hideki Hanaoka,Yoshio Kobayashi	2016	3
14	Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study BMJ Open ·Sonoko Misawa,Yasunori Sato,K. Katayama,Hideki Hanaoka,Setsu Sawai,Minako Beppu,Fumio Nomura,Kazumoto Shibuya,Yukari Sekiguchi,Yuta Iwai,Keisuke Watanabe,Hiroshi Amino,Chikako Ohwada,Masahiro Takeuchi,Emiko Sakaida,Chiaki Nakaseko,Satoshi Kuwabara	2015	40
15	Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial) BMJ Open ·Reiko Aoyagi,Hiromichi Hamada,Yasunori Sato,Hiroyuki Suzuki,Yoshihiro Onouchi,Ryota Ebata,Kengo Nagashima,Moe Terauchi,Masaru Terai,Hideki Hanaoka,Akira Hata	2015	22
16	A single blind randomized controlled clinical trial of mexiletine in amyotrophic lateral sclerosis: Efficacy and safety of sodium channel blocker phase II trial Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration ·Kazumoto Shibuya,Sonoko Misawa,Hideki Kimura,Yu-ichi Noto,Yasunori Sato,Yukari Sekiguchi,Yuta Iwai,Satsuki Mitsuma,Minako Beppu,Keisuke Watanabe,Yumi Fujimaki,Yukiko Tsuji,Toshio Shimizu,Toshiki Mizuno,Masanori Nakagawa,Kyoko Sawaguchi,Hideki Hanaoka,Satoshi Kuwabara	2015	35
17	OsNIP3;1, a rice boric acid channel, regulates boron distribution and is essential for growth under boron‐deficient conditions The Plant Journal ·Hideki Hanaoka,Shimpei Uraguchi,Junpei Takano,M. Tanaka,Toru Fujiwara	2014	78
18	Strategy for treating selective serotonin reuptake inhibitor-resistant social anxiety disorder in the clinical setting: a randomised controlled trial protocol of cognitive behavioural therapy in combination with conventional treatment BMJ Open ·Naoki Yoshinaga,Tomihisa Niitsu,Hideki Hanaoka,Yasunori Sato,Fumiyo Ohshima,Satoshi Matsuki,Osamu Kobori,Michiko Nakazato,Akiko Nakagawa,Masaomi Iyo,Eiji Shimizu	2013	14
19	A prioritization analysis of disease association by data-mining of functional annotation of human genes Genomics ·Takayuki Taniya,Susumu Tanaka,Yumi Yamaguchi‐Kabata,Hideki Hanaoka,Chisato Yamasaki,Harutoshi Maekawa,Roberto A. Barrero,Boris Lenhard,Milton W. Datta,Mary Shimoyama,Roger E. Bumgarner,Ranajit Chakraborty,Ian Hopkinson,Libin Jia,(unknown),Charles Auffray,Satoshi Minoshima,Tadashi Imanishi,Takashi Gojobori	2011	8
20	A Phase I-II Study of α-Galactosylceramide-Pulsed IL-2/GM-CSF-Cultured Peripheral Blood Mononuclear Cells in Patients with Advanced and Recurrent Non-Small Cell Lung Cancer The Journal of Immunology ·Shinichiro Motohashi,Kaoru Nagato,Naoki Kunii,Heizaburo Yamamoto,Kazuki Yamasaki,Kohsuke Okita,Hideki Hanaoka,Naomi Shimizu,Makoto Suzuki,Ichiro Yoshino,Masaru Taniguchi,Takehiko Fujisawa,Toshinori Nakayama	2009	174

About Hideki Hanaoka

Hideki Hanaoka is a scholar working on Toxicology, Obstetrics and Gynecology and Oncology, having authored 78 papers that have together received 2.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (7 papers), Endometrial and Cervical Cancer Treatments (7 papers), CAR-T cell therapy research (5 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Mental Health Research Topics (4 papers), Cervical Cancer and HPV Research (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). The work is most often cited by research in Immunology (626 citations), Plant Science (951 citations) and Oncology (542 citations). Hideki Hanaoka has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Tomohiko Kato, Yoshinori Ohsumi, Takeshi Noda, Satoshi Tabata, Shusei Sato, Kohki Yoshimoto, Yumiko Shirano, Daisuke Shibata, Hiroaki Hayashi and Toshinori Nakayama. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact